Literature DB >> 23919105

Radiological diagnosis and staging of hilar cholangiocarcinoma.

Carlos Valls1, Sandra Ruiz, Laura Martinez, David Leiva.   

Abstract

Hilar cholangiocarcinoma is a rare malignant tumor arising from the epithelium of the bile ducts. Surgery is still the only chance of potentially curative treatment in patients with perihilar cholangiocarcinoma. However, radical resection requires aggressive surgical strategies that should be tailored optimally according to the location, size and vascular invasion of the tumors. Accurate diagnosis and staging of these tumors is therefore critical for optimal treatment planning and for determining a prognosis. Multidetector computed tomography (MDCT), magnetic resonance imaging (MRI) and MR cholangiography are useful tools, both to diagnose and stage hilar cholangiocarcinoma. Modern imaging techniques allow accurate detection of the level of obstruction and the longitudinal and radial spread of the tumor. In addition, high-resolution MDCT and MR provide specific radiographic features to determine vascular involvement of anatomic structures, such as the hepatic artery or the portal vein, which are critical to decide the surgical strategy. Finally, radiological staging allows detection of patients with distant metastasis in the liver or peritoneum who will not benefit from a surgical approach.

Entities:  

Keywords:  Cholangiocarcinoma; Hepatic resection; Magnetic resonance imaging; Multidetector computed tomography; Radiological staging

Year:  2013        PMID: 23919105      PMCID: PMC3731524          DOI: 10.4251/wjgo.v5.i7.115

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  38 in total

Review 1.  Autoimmune pancreatitis and IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Kensuke Takuma; Naoto Egawa; Koji Tsuruta; Tsuneo Sasaki
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-15       Impact factor: 46.802

2.  Proximal bile duct stricture disguised as malignant neoplasm.

Authors:  A Nakayama; H Imamura; R Shimada; S Miyagawa; M Makuuchi; S Kawasaki
Journal:  Surgery       Date:  1999-05       Impact factor: 3.982

3.  HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma.

Authors:  A S Fulcher; M A Turner
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

Review 4.  Epidemiology of cholangiocarcinoma: an update focusing on risk factors.

Authors:  Hai-Rim Shin; Jin-Kyoung Oh; Eric Masuyer; Maria-Paula Curado; Veronique Bouvard; Yue-Yi Fang; Surapon Wiangnon; Banchob Sripa; Sung-Tae Hong
Journal:  Cancer Sci       Date:  2009-12-04       Impact factor: 6.716

5.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

6.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

7.  Risk factors for gallbladder cancer. An international collaborative case-control study.

Authors:  B L Strom; R D Soloway; J L Rios-Dalenz; H A Rodriguez-Martinez; S L West; J L Kinman; M Polansky; J A Berlin
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

8.  Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography.

Authors:  J A Soto; M A Barish; E K Yucel; D Siegenberg; J T Ferrucci; R Chuttani
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

Review 9.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

10.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.

Authors:  Tania M Welzel; Barry I Graubard; Hashem B El-Serag; Yasser H Shaib; Ann W Hsing; Jessica A Davila; Katherine A McGlynn
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-06       Impact factor: 11.382

View more
  8 in total

Review 1.  Computed Tomography Versus Magnetic Resonance Imaging for Hepatic Lesion Characterization/Diagnosis.

Authors:  Khaled Y Elbanna; Ania Z Kielar
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 2.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

3.  Hilar cholangiocarcinoma.

Authors:  José M Ramia
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

Review 4.  Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

Authors:  Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

5.  Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum.

Authors:  Mangal S Mahajan; Srikanth Moorthy; Sreekumar P Karumathil; R Rajeshkannan; Ramchandran Pothera
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

Review 6.  Abdominal cross-sectional imaging of the associating liver partition and portal vein ligation for staged hepatectomy procedure.

Authors:  Michele Zerial; Dario Lorenzin; Andrea Risaliti; Chiara Zuiani; Rossano Girometti
Journal:  World J Hepatol       Date:  2017-06-08

7.  Hepatocellular carcinoma with hilar bile duct tumor thrombus versus hilar Cholangiocarcinoma on enhanced computed tomography: a diagnostic challenge.

Authors:  Xiaoqi Zhou; Jifei Wang; Mimi Tang; Mengqi Huang; Ling Xu; Zhenpeng Peng; Zi-Ping Li; Shi-Ting Feng
Journal:  BMC Cancer       Date:  2020-01-22       Impact factor: 4.430

8.  A case series of hilar cholangiocarcinoma: A single surgeon experience over 20-years.

Authors:  Salam Daradkeh
Journal:  Ann Med Surg (Lond)       Date:  2021-01-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.